ALKERMES | ALKS - Reddito Netto

Prezzo Delle Azioni
33.31
Cambio Giornaliero
-0.60 -1.77%
Mensile
13.42%
Annuale
19.65%
Q2 Previsione
32.32




Reddito Netto Cambiamento Data
AbbVie USD 1.82B 1.63B 2025-12
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Coherus Biosciences USD -37.64M 2.11M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
J&J USD 5.24B 119M 2026-03
Malin Corporation EUR -1.1M 2.2M 2023-12
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Otsuka Holdings JPY 65.49B 58.64B 2025-12
Ovoca Bio EUR -765K 4.89M 2025-06
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12